Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sculptra in aesthetic medicine
NCT00447551Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jan 2007
- Primary completion
- Apr 2008
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of poly(L-lactic acid) in Skin aging, sponsored by Valeant Pharmaceuticals. Primary endpoint: Degree of correction achievable with Sculptra at 6 months. Started Jan 2007; status: completed.
02
Drugs
poly(L-lactic acid)
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT00447551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447551.